United States
Choose your country or region:
France
Germany
Italy
Japan
United Kingdom
About
Leadership
Board of Directors
Company History
Corporate Impact and Community Relations
Our Collaborations
Contact Us
Newsroom
News & Stories
Press Releases
Multimedia
Our Tests
Cologuard®
OncoExTra™
Oncoguard® Liver
Oncotype DX®
Oncotype DX Breast DCIS Score®
Oncotype DX Breast Recurrence Score®
Oncotype DX Colon Recurrence Score®
Riskguard™
Pipeline & Data
Breast Radiation Score
Cologuard® 2.0
Colorectal Cancer Blood
LBgard® Blood Tubes
Molecular Residual Disease
Multi-Cancer Early Detection
Clinical Studies
Research
Publications & Abstracts
Exact Academy
Investor Relations
Press Releases
Events & Presentations
Corporate Governance
Stock Information
Financial Information
Email Alerts
Contact Us
Join Our Team
×
DIGITAL NEWSROOM
Posts in:
Investor Relations
December 22, 2015
Exact Sciences to participate in J.P. Morgan 2016 Healthcare Conference
November 04, 2015
Exact Sciences to Participate in November Investor Conferences
November 02, 2015
Exact Sciences Aims to Collaborate with City of Madison & University of Wisconsin in Developing a Biotech Campus
October 29, 2015
View Slides from our Third quarter 2015 earnings call
October 29, 2015
Cologuard(R) Growth Trajectory Increases to 34,000 Completed Tests, Generates $12.6M in Revenue in Third Quarter 2015
October 06, 2015
View Webcast Archive and Slides from Exact Sciences' Conference Call Regarding USPSTF Draft Recommendations
August 31, 2015
Exact Sciences to Participate in Baird Healthcare Conference
April 20, 2015
Exact Sciences to host first-quarter 2015 results webcast and call
March 05, 2015
Our Presentation at Cowen and Company 35th Annual Health Care Conference
January 30, 2015
Cologuard® Blitzes the Marketplace at J.P. Morgan
January 29, 2015
Exact Sciences Announces Norton Healthcare to Adopt Cologuard
November 26, 2014
Watch Exact Sciences Chairman and CEO Kevin Conroy's Appearance on CNBC's Mad Money
1
2
3
